Active Interleukin 26 (IL26) Homo sapiens (Human) Active protein

AK155

Add to Cart Distributors
Overview
Properties
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Pointn/a
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Interleukin 26 (IL26) Packages (Simulation)
  • Active Interleukin 26 (IL26) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Usage

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapyPubMed: 23177721
  • IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.pubmed:28879509
  • Increased interleukin-26 expression promotes Th17 and Th2-associated cytokine production by keratinocytes in atopic dermatitisPubmed: 31465744
  • Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathwayPubmed: 32041953
  • METHOD OF MANUFACTURING BISPECIFIC ANTIBODIES, BISPECIFIC ANTIBODIES AND THERAPEUTIC USE OF SUCH ANTIBODIES
  • IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer33456560

Recommend products